Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 19.01 crore in Q1FY24, growth of 26.66% Y-o-Y
Total Income for Q1FY24 grew 10.27% Y-o-Y to Rs. 143.31 crore. Company has set a target of achieving Rs. 750 crore revenue by FY26 Financial Highlights (Standalone) Q1 FY24 Q1 FY23 Y-O-Y FY23 FY22 Y-O-Y Total Income 143.31 129.97 10.27% 532.79 482.08 10.52% EBITDA 28.41 23.41 21.36% 111.65 105.47 5.86% Profit before Tax 25.45 […]
Continue Reading